These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 26494924)
21. The cytoprotective impact of yes-associated protein 1 after ischemia-reperfusion injury in AC16 human cardiomyocytes. Khan K; Makhoul G; Yu B; Schwertani A; Cecere R Exp Biol Med (Maywood); 2019 Jul; 244(10):802-812. PubMed ID: 31142144 [TBL] [Abstract][Full Text] [Related]
22. Puma joins the battery of BH3-only proteins that promote death and infarction during myocardial ischemia. Webster KA Am J Physiol Heart Circ Physiol; 2006 Jul; 291(1):H20-2. PubMed ID: 16772523 [No Abstract] [Full Text] [Related]
23. Overexpression of A kinase interacting protein 1 attenuates myocardial ischaemia/reperfusion injury but does not influence heart failure development. Booij HG; Yu H; De Boer RA; van de Kolk CW; van de Sluis B; Van Deursen JM; Van Gilst WH; Silljé HH; Westenbrink BD Cardiovasc Res; 2016 Aug; 111(3):217-26. PubMed ID: 27302402 [TBL] [Abstract][Full Text] [Related]
24. The mAKAP signalosome and cardiac myocyte hypertrophy. Bauman AL; Michel JJ; Henson E; Dodge-Kafka KL; Kapiloff MS IUBMB Life; 2007 Mar; 59(3):163-9. PubMed ID: 17487687 [TBL] [Abstract][Full Text] [Related]
25. E2F1-dependent miR-421 regulates mitochondrial fragmentation and myocardial infarction by targeting Pink1. Wang K; Zhou LY; Wang JX; Wang Y; Sun T; Zhao B; Yang YJ; An T; Long B; Li N; Liu CY; Gong Y; Gao JN; Dong YH; Zhang J; Li PF Nat Commun; 2015 Jul; 6():7619. PubMed ID: 26184432 [TBL] [Abstract][Full Text] [Related]
26. The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling. Pare GC; Bauman AL; McHenry M; Michel JJ; Dodge-Kafka KL; Kapiloff MS J Cell Sci; 2005 Dec; 118(Pt 23):5637-46. PubMed ID: 16306226 [TBL] [Abstract][Full Text] [Related]
27. Tripartite Motif 8 Contributes to Pathological Cardiac Hypertrophy Through Enhancing Transforming Growth Factor β-Activated Kinase 1-Dependent Signaling Pathways. Chen L; Huang J; Ji YX; Mei F; Wang PX; Deng KQ; Jiang X; Ma G; Li H Hypertension; 2017 Feb; 69(2):249-258. PubMed ID: 27956576 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway. Kuwabara Y; Horie T; Baba O; Watanabe S; Nishiga M; Usami S; Izuhara M; Nakao T; Nishino T; Otsu K; Kita T; Kimura T; Ono K Circ Res; 2015 Jan; 116(2):279-88. PubMed ID: 25362209 [TBL] [Abstract][Full Text] [Related]
29. Ischemia/reperfusion injury is increased and cardioprotection by a postconditioning protocol is lost as cardiac hypertrophy develops in nandrolone treated rats. Penna C; Tullio F; Perrelli MG; Moro F; Abbadessa G; Piccione F; Carriero V; Racca S; Pagliaro P Basic Res Cardiol; 2011 May; 106(3):409-20. PubMed ID: 21174210 [TBL] [Abstract][Full Text] [Related]
30. Discovery of Potential Therapeutic miRNA Targets in Cardiac Ischemia-Reperfusion Injury. Zhou Y; Chen Q; Lew KS; Richards AM; Wang P J Cardiovasc Pharmacol Ther; 2016 May; 21(3):296-309. PubMed ID: 26396139 [TBL] [Abstract][Full Text] [Related]
31. Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cheng Y; Zhu P; Yang J; Liu X; Dong S; Wang X; Chun B; Zhuang J; Zhang C Cardiovasc Res; 2010 Aug; 87(3):431-9. PubMed ID: 20219857 [TBL] [Abstract][Full Text] [Related]
32. JIP3 deficiency attenuates cardiac hypertrophy by suppression of JNK pathway. Ma Q; Liu Y; Chen L Biochem Biophys Res Commun; 2018 Sep; 503(1):1-7. PubMed ID: 29604277 [TBL] [Abstract][Full Text] [Related]
33. Cytoprotective effect of bis(1-oxy-2-pyridinethiolato)oxovanadiun(IV) on myocardial ischemia/reperfusion injury elicits inhibition of Fas ligand and Bim expression and elevation of FLIP expression. Bhuiyan MS; Shibuya M; Shioda N; Moriguchi S; Kasahara J; Iwabuchi Y; Fukunaga K Eur J Pharmacol; 2007 Oct; 571(2-3):180-8. PubMed ID: 17658509 [TBL] [Abstract][Full Text] [Related]
34. miR-21: a miRaculous Socratic paradox. da Costa Martins PA; De Windt LJ Cardiovasc Res; 2010 Aug; 87(3):397-400. PubMed ID: 20562424 [No Abstract] [Full Text] [Related]
35. MiR-221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression. Wang C; Wang S; Zhao P; Wang X; Wang J; Wang Y; Song L; Zou Y; Hui R J Cell Biochem; 2012 Jun; 113(6):2040-6. PubMed ID: 22275134 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-297 promotes cardiomyocyte hypertrophy via targeting sigma-1 receptor. Bao Q; Zhao M; Chen L; Wang Y; Wu S; Wu W; Liu X Life Sci; 2017 Apr; 175():1-10. PubMed ID: 28286226 [TBL] [Abstract][Full Text] [Related]
37. YAP in tumorigenesis: Friend or foe? Liu S; Pang Q; Zhang J; Liu C J Hepatol; 2015 Jun; 62(6):1444. PubMed ID: 25687424 [No Abstract] [Full Text] [Related]
38. MicroRNA-93 inhibits ischemia-reperfusion induced cardiomyocyte apoptosis by targeting PTEN. Ke ZP; Xu P; Shi Y; Gao AM Oncotarget; 2016 May; 7(20):28796-805. PubMed ID: 27119510 [TBL] [Abstract][Full Text] [Related]
39. Reply to: "YAP in tumorigenesis: Friend or foe?". Perra A; Kowalik MA; Giordano S; Columbano A J Hepatol; 2015 Jun; 62(6):1445. PubMed ID: 25701465 [No Abstract] [Full Text] [Related]
40. Reciprocal regulation of miR-23a and lysophosphatidic acid receptor signaling in cardiomyocyte hypertrophy. Yang J; Nie Y; Wang F; Hou J; Cong X; Hu S; Chen X Biochim Biophys Acta; 2013 Aug; 1831(8):1386-94. PubMed ID: 23711961 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]